Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Oct 27, 2026
TickeronGET DAILY SIGNALS
AptarGroup (ATR) vs Rush Street Interactive (RSI): Stability Against High-Growth Momentum

AptarGroup (ATR) vs Rush Street Interactive (RSI): Stability Against High-Growth Momentum

Key Takeaways

  • AptarGroup (ATR) is a diversified drug-delivery and consumer-dispensing leader, while Rush Street Interactive (RSI) is a fast-growing online casino and sports-betting operator — two very different risk-reward profiles.
  • ATR offers stability, a quarterly dividend, and steady but modest growth, yet it is navigating margin compression and pharma destocking headwinds.
  • RSI is delivering high double-digit revenue growth, record profitability, and a debt-free balance sheet, but it carries higher volatility and regulatory exposure.
  • Relative performance has diverged sharply: RSI has generated a strong trailing one-year return, while ATR shares have declined over the past year.
  • Market sentiment currently leans more constructive on RSI's growth trajectory, whereas ATR is viewed as a defensive, cash-returning compounder.
  • Get more detail on each name's latest headlines and intraday moves: ATR Major News and ATR Today's Price Move, plus RSI Major News and RSI Today's Price Move.
  • For automated, data-driven ideas across the market, explore the curated Trending AI Robots.

Setting the Scene

Investors weighing these two stocks are effectively choosing between a mature industrial-healthcare franchise and a high-growth consumer technology company. ATR, AptarGroup, supplies dispensing and drug-delivery systems used by pharmaceutical and consumer brands worldwide. RSI, Rush Street Interactive, operates online casino and sports-betting platforms across North and Latin America. The comparison is relevant to traders assessing momentum and growth potential, as well as longer-term investors evaluating earnings stability, cash returns, and sector risk. Their divergent business models, growth rates, and recent market behavior make this an instructive head-to-head study in market positioning and relative performance.

AptarGroup (ATR) Overview and Recent Performance

AptarGroup is a global leader in drug-delivery, dosing, and protection technologies, serving pharmaceutical, beauty, food-and-beverage, and personal-care markets from more than 20 countries. Its three segments — Pharma, Beauty, and Closures — provide broad diversification. In recent quarters, the company reported record revenue exceeding $1 billion, driven by strength in injectables, biologics, and GLP-1-related therapies, as well as consumer healthcare applications such as nasal decongestants and eye-care solutions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

However, recent market activity has been characterized by margin compression. Adjusted EBITDA margins declined as emergency-medicine destocking weighed on prescription sales, while higher input costs and temporary operational issues pressured the Beauty and Closures segments. Management has guided to improving margins as destocking abates, and the company continues returning capital through a quarterly dividend and share repurchases. Still, shares have declined over the past year, and the stock has underperformed its broader industry.

Rush Street Interactive (RSI) Overview and Recent Performance

Rush Street Interactive is an online casino and sports-betting company operating in the United States, Canada, and Latin America, with a "casino-first" strategy in which online casino represents the majority of revenue. Recent results have been notably strong: quarterly revenue rose roughly 46% year over year to a record, adjusted EBITDA climbed about 61%, and monthly active users (MAUs) increased by more than 50%. The company has raised its full-year guidance, and it launched operations in Alberta during the recent period.

Growth is being fueled by market-share gains in North American iGaming, expansion in Latin America, and a favorable World Cup-driven period, alongside a debt-free balance sheet and an active share-buyback program. At the same time, the stock has been volatile, pulling back notably over the past month despite a strong year-to-date advance. Regulatory and tax developments in markets such as Colombia, along with rising marketing spend, remain key variables that could influence profitability and sentiment going forward.

Head-to-Head Comparison

The most fundamental contrast is business model. ATR is an industrial manufacturer with recurring demand tied to pharmaceutical consumption and consumer products; it grows steadily but is exposed to input costs, product mix, and destocking cycles. RSI is a digital consumer platform whose revenue is tied to player engagement, market access, and regulatory outcomes; it grows far faster but with higher volatility and geographic concentration risk.

On growth, the gap is wide — RSI's revenue has been expanding at a double-digit pace, while ATR's growth is more modest and recently constrained by margin pressure. On stability, the advantage reverses: ATR generates consistent cash flow, pays a dividend, and has decades of operating history, whereas RSI reinvests heavily in marketing and faces evolving gaming regulations and taxes. From a market-sentiment standpoint, RSI carries stronger upward momentum and a more bullish analyst posture, but with a recent sharp pullback. ATR, by contrast, is viewed more defensively, supported by share repurchases and a long-term pharma growth target in the high single-digit to low double-digit range.

AI-Driven Perspective

Based on observable factors — trend consistency, momentum, catalysts, and relative positioning — Tickeron's AI would likely tilt toward RSI for traders prioritizing growth and price momentum, given its accelerating revenue, record profitability, and upward guidance revisions. However, that preference would come with recognition of RSI's higher volatility and regulatory risk. For stability-oriented or risk-averse profiles, the AI might favor ATR's steadier cash generation, dividend, and diversified end markets, particularly as near-term destocking headwinds begin to ease. The verdict is probabilistic rather than definitive: momentum currently appears stronger in RSI, while durability and downside resilience appear stronger in ATR.

Using Tickeron’s Trending AI Robots for Deeper Insights

In my research process, I often turn to Tickeron’s Trending AI Robots to review how algorithmic strategies are performing across names like these. The page highlights only the best-performing and most market-appropriate AI trading bots, each with its own trading style, strategy, timeframe, performance history, and set of covered symbols. Because market conditions change constantly, the bots featured are those judged most suitable for the current environment. Exploring the page lets traders review bot statistics, strategies, and track records side by side, providing a convenient starting point for applying algorithmic analysis to stocks such as ATR and RSI.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ATR, RSI

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


ATR in upward trend: price rose above 50-day moving average on October 22, 2026

ATR moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 60%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ATR as a result. In 38 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 46%.

The Moving Average Convergence Divergence (MACD) for ATR just turned positive on October 14, 2026. Looking at past instances where ATR's MACD turned positive, the stock continued to rise in 31 of 58 cases over the following month. The odds of a continued upward trend are 53%.

Following a +1.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATR advanced for three days, in 181 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

Bearish Trend Analysis

The 10-day RSI Indicator for ATR moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 12 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 36%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for ATR moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

ATR broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ATR entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. ATR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.074) is normal, around the industry mean (4.950). P/E Ratio (22.691) is within average values for comparable stocks, (37.710). Projected Growth (PEG Ratio) (2.595) is also within normal values, averaging (4.143). Dividend Yield (0.015) settles around the average of (0.005) among similar stocks. P/S Ratio (2.072) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 9.57B. The market cap for tickers in the group ranges from 126 to 159.55B. ISRG holds the highest valuation in this group at 159.55B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 0%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 10%. OSUR experienced the highest price growth at 13%, while NXGL experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -47%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 53
Price Growth Rating: 53
SMR Rating: 81
Profit Risk Rating: 94
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
ATR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of consumer dispensing systems

Industry PharmaceuticalsOther

Industry
Containers Or Packaging
Address
265 Exchange Drive
Phone
+1 815 477-0424
Employees
14000
Web
https://www.aptar.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.